PSOC Penn Liver Cancer: pre-Malignant Stiffening, Membrane Transduction, & Nuclear Rheology, The Transdisciplinary nature of Cancer Physics requires efficient and effective interactions across multiple boundaries. We have chosen to focus on primary liver cancer, predominantly hepatocellular carcinoma (HCC), which are highly morbid tumors that represent the third most common cause of cancer death worldwide. HCC almost always arises in the setting of end-stage liver fibrosis, termed cirrhosis, and new in situ methods of measuring liver stiffness are emerging as effective predictors of the relative risk of HCC. Patients with stiffer livers demonstrate dramatically increased rates of HCC, but clinical acceptance will no doubt be helped by - or even require - studies proposed here. We seek to determine the nature of the relationships between human HCC with fresh primary samples and the mechanics of liver tissues, the signals to cells, and the roles of nuclear mechanics in DNA stability and tumor growth. Five clinicians at Penn who regularly see patients or samples with liver disease and liver cancer are involved in the proposed PSOC Penn, and so the opportunities to impact the Clinic are tangible. In formulating this cross-cutting proposal with 3 Research Projects and 2 Cores, we propose a Multi-PI Leadership Plan to best represent the diverse areas of expertise and responsibility: Dennis Discher PhD (Prof. Eng'g Appl Sci, Grad Groups Physics, Cell & Molec Biol) Contact PI, Admin Core Lead, PI of Project-3 Nuclear Rheology: Cancer Cell line Expertise. Paul Janmey PhD (Prof. Physiology, Physics, and Bioengineering) PI of Project-1 Liver Mechanics: Cancer Cell line Expertise. Rebecca Wells MD (Assoc. Prof. Medicine, Pathology, and Laboratory Medicine) PI of Core-1 Liver Cancer Tissue and Models: Expertise in Mechanisms of Liver Disease. David E. Kaplan MD (Asst. Professor of Medicine, and Director of Hepatology) Co-PI of Core-1 Liver Cancer Tissue and Models: Clinical Expertise in Liver Cancer. Andrea Liu PhD (Prof. Physics and Chemistry) PI of Core-2 Theory: Expertise in Statistical Physics Modeling. Penn is a single, integrated Campus, with all of the labs involved in the Center walkable within 5-10 minutes, and Penn's Medical Center Hospital serves the greater Philadelphia area with one of the larger liver disease centers in the country. To integrate the proposed PSOC Penn within the University's broad and deep efforts in Cancer, all leaders and faculty members of the PSOC will become members of Penn's Abramson Cancer Center (if they are not already). The Director of the Abramson Cancer Center, Prof. Chi Van Dang, will be PI of Pilot Project-1 and will be a key member of the Center Advisory Committee. More broadly, the PSOC Penn will support through Education & Outreach a wide variety of programs that aim to build a vibrant community of students and fellows who embody the multidisciplinary approach to understanding the physics of cancer with an aim of transforming the next generation of scientists, engineers and clinicians.

Public Health Relevance

Relevance to Public Health SIGNIFICANCE: There is Physics to Cancer. Tumors grow in size. Cancer cells move. Tissues change mechanically, often getting stiffer, sometimes softer, often heterogeneously. Primary liver cancer is representative and is unfortunately increasing rapidly in frequency among Americans. It almost always arises in the setting of end- stage liver fibrosis, termed cirrhosis such as occurs with alcohol consumption. Measuring liver stiffness is now possible in patients, and patients with stiffer livers demonstrate dramatically increased rates of liver cancer, at least based on several European reports. Clinical acceptance will no doubt be helped by - or even require - the types of `physics of cancer' studies proposed here. We seek to determine the nature of the relationships between liver cancer and the mechanical changes of liver tissues, the altered signals to cells, and the roles of nuclear mechanics in DNA stability and tumor growth. Our Team at Penn involves liver and cancer experts, as well as physical scientists and engineers who conduct diverse biophysical experiments, plus accomplished theorists who take multi-scale modeling approaches to clarifying and predicting biophysical phenomena. We can focus on human disease at Penn, not just culture or animal models, and we can quickly translate insights back to the clinicians. Penn is a single, integrated Campus, with all of the lab involved in the Center walkable within 5-10 minutes as is the University of Pennsylvania Hospital, which serves the greater Philadelphia area with one of the larger liver disease centers in the country. The significance of this opportunity for Physics to impact an important and highly morbid cancer is already clear to the assembled Team and will hopefully be clear to the broader Public if supported. Average Scores of the Components: Overall: 2.9 Project 1: 3.4 Project 2: 4.2 Project 3: 2.8 Resource Core 1: 2.4 Resource Core 2: 2.7 Education and Outreach: 2.7

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
1U54CA193417-01
Application #
8866921
Study Section
Special Emphasis Panel (ZCA1-TCRB-5 (J1))
Program Officer
Hanlon, Sean E
Project Start
2015-06-16
Project End
2020-05-31
Budget Start
2015-06-16
Budget End
2016-05-31
Support Year
1
Fiscal Year
2015
Total Cost
$1,949,670
Indirect Cost
$704,670
Name
University of Pennsylvania
Department
Type
Schools of Engineering
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Lee, Calvin K; de Anda, Jaime; Baker, Amy E et al. (2018) Multigenerational memory and adaptive adhesion in early bacterial biofilm communities. Proc Natl Acad Sci U S A 115:4471-4476
Nair, Praful R; Alvey, Cory; Jin, Xiaoling et al. (2018) Filomicelles Deliver a Chemo-Differentiation Combination of Paclitaxel and Retinoic Acid That Durably Represses Carcinomas in Liver to Prolong Survival. Bioconjug Chem 29:914-927
Huang, Mo; Wang, Jingshu; Torre, Eduardo et al. (2018) SAVER: gene expression recovery for single-cell RNA sequencing. Nat Methods 15:539-542
Ban, Ehsan; Franklin, J Matthew; Nam, Sungmin et al. (2018) Mechanisms of Plastic Deformation in Collagen Networks Induced by Cellular Forces. Biophys J 114:450-461
Smith, Lucas R; Cho, Sangkyun; Discher, Dennis E (2018) Stem Cell Differentiation is Regulated by Extracellular Matrix Mechanics. Physiology (Bethesda) 33:16-25
Holle, Andrew W; Young, Jennifer L; Van Vliet, Krystyn J et al. (2018) Cell-Extracellular Matrix Mechanobiology: Forceful Tools and Emerging Needs for Basic and Translational Research. Nano Lett 18:1-8
Pfeifer, Charlotte R; Xia, Yuntao; Zhu, Kuangzheng et al. (2018) Constricted migration increases DNA damage and independently represses cell cycle. Mol Biol Cell 29:1948-1962
Xia, Yuntao; Ivanovska, Irena L; Zhu, Kuangzheng et al. (2018) Nuclear rupture at sites of high curvature compromises retention of DNA repair factors. J Cell Biol 217:3796-3808
Ramakrishnan, N; Bradley, Ryan P; Tourdot, Richard W et al. (2018) Biophysics of membrane curvature remodeling at molecular and mesoscopic lengthscales. J Phys Condens Matter 30:273001
Chen, Gang; Huang, Alexander C; Zhang, Wei et al. (2018) Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature 560:382-386

Showing the most recent 10 out of 68 publications